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A PRELIMINARY STUDY ON EXTERNAL COUNTERPULSATION SYSTEM: AN 
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In order to address the long-term complications that arise from poor venous return, a hallmark 
of the Fontan physiology, we assessed the feasibility of a non-invasive, home therapy that will 
improve the health of the patient during the heart transplant waiting period and ameliorate the 
quality of life. In order to achieve this goal we tested a device that applies pressure to the lower 
extremities of the body (legs and abdomen) in a pulsating fashion with the goal of augmenting 
systemic blood flow to the pulmonary arteries. This treatment will enhance flow from the great 
veins and through the lungs and serve as adjunctive clinical treatment of single ventricle 
physiology. 
 
The specific aim of this study was to show improvements in cardiorespiratory measurements 
after applying external pressure as a proxy for improved health in the Fontan patient. Various 
studies have shown the impaired exercise capacity of post-operative Fontan patients, but very 
ix 
 
 
little data exists focusing on a period much later after the surgery. Our results among the two 
subjects completed so far have shown a moderately beneficial improvement in exercise 
capacity after the compression therapy.  
 
Subjects performed a treadmill exercise stress test at VCU that was followed by six days of 
applied external pressure treatment and finished with a final post-treatment stress test. 
Cardiorespiratory data was collected and analyzed for improvements from base level.  
 
Overall an improvement in exercise duration time, VO2 peak, ventilatory threshold, and OUES 
was observed, with only VE / VCO2 slope having mixed results. Both subjects seem to be 
relatively healthy Fontan patients, as indicated by their VO2 peak, VE/VCO2 slope and OUES. As 
a result, benefits of treatment may vary among a cohort of Fontan patients with poor health 
condition; a failing Fontan physiology for instance. The improvement in exercise capacity 
suggests that this therapy could be very beneficial to Fontan patients. These results warrants 
follow up studies to explore the extent of the clinical benefits of compression treatment among 
the Fontan population.  
 
A Preliminary Study On External Counterpulsation System: 
An Alternative Therapeutic Option for Fontan Patients 
Joseph Hernandez 
Virginia Commonwealth University 
 
1 
 
CHAPTER 1: Motivation and Significance 
 
1.1 BACKGROUND 
In the U.S., approximately 1 million babies are born annually with 
a heart defect in need of corrective treatment. 40,000 of these are 
born with congenital heart disease (CHD) requiring surgical 
intervention [45]. A further subset, approximately 8,000 to 9,000 
children (or 2 per 1,000 births), are born with a malformed heart 
that only has a single ventricle, essentially half a heart. In the first 
year of life, single ventricle heart defects are the leading cause of 
death from all birth defects in the U.S. [46]. 
 
This particular heart defect causes oxygenated and deoxygenated 
blood to mix in the heart and immediate surgical intervention is 
required for survival. The standard surgical procedure attempts to 
redirect the major veins (that would have connected to the 
missing portion of the heart) directly to the lungs in order to 
separate the oxygen-/deoxygenated blood flow going into the 
body (Fontan Surgery). While this new blood flow system is life 
saving, in the long run, it will contribute to deteriorating health for 
the patient. 
 
Fontan Procedure
Glenn Procedure
Norwood Procedure
Figure 1: Three successive heart 
surgeries 
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1.2 THE FONTON PROCEDURE 
In patients born with this single-ventricle malformation of the heart, 3 successive heart 
surgeries are required. Each stage is named after the surgeon who pioneered the technique. 
The single ventricle has to maintain both the systemic and the pulmonary blood circulation, 
prior to these heart surgeries. In order to correct the two major problems with single-
ventricular physiology, (1) arterial desaturation and (2) chronic volume overload to the single 
ventricle, these surgeries separate the systemic and pulmonary circulation, achieving near 
normal arterial saturation and eliminating the volume overload problem.  
 
The primary reason for a staged approach is that at birth the pulmonary vascular resistance is 
still elevated for several weeks. A cavopulmonary shunt would also be impossible, considering 
the caval veins and pulmonary arteries are usually too small at this point. This staged approach 
also allows the body to adopt progressively to this new physiology and reduces operative 
morbidity and mortality. 
 
Norwood Procedure 
Immediately after birth, the patient undergoes the first of three procedures, the Norwood 
procedure. Here a "systemic-to-pulmonary" arterial shunt is used to provide blood flow to the 
lungs. The main goal in this step is to provide pulmonary blood flow sufficient to allow 
adequate oxygen delivery to tissues and pulmonary arterial growth. 
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Glenn Procedure 
Once the older infant displays low risk of elevated pulmonary vascular resistance, the shunt is 
removed and the superior vena cava is subsequently attached to the pulmonary artery. At age 
4-12 months, the cavopulmonary connection, or the bidirectional Glenn shunt will be 
performed. If no other blood flow is allowed to the lungs, the volume load to the heart is 
significantly decreased to slightly less than normal. At this stage, the patient will remain slightly 
cyanotic, as the desaturated blood from the inferior caval vein is still allowed to flow to the 
aorta. This will be corrected in the third and final stage. 
 
Fontan Procedure 
This is the final procedure and usually occurs between the ages of 3 and 5 years old. The 
inferior vena cava is now connected to the pulmonary artery, completely bypassing the right 
heart in this step and completing a Total Cavopulmonary Connection (TCPC). Here the caval 
veins are connected to the pulmonary artery, bypassing the right ventricle and the right atrium. 
The superior caval vein was connected to the pulmonary artery during the second stage surgery 
(the Glenn Procedure). 
 
Immediately after the Fontan surgery, ventricular preload will significantly decrease, 
subsequently increasing pulmonary blood flow. Exercise capacity has been shown to increase 
significantly immediately following the Fontan surgery, with exercise duration by approximately 
40% and VO2 max by 20% [1]. 
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1.3 SINGLE-VENTRICLE / FONTON PHYSIOLOGY 
These surgeries are a high-risk operation with survival rates ranging from 50% to 70% [2]. The 
end result is a surgeon-made physiology in which a single ventricle drives blood flow through 
the systemic and pulmonary circulations without a subpulmonary pressure source.  These 
patients live with an abnormal circulatory status and are at high risk of developing congestive 
heart failure [43].  
 
This surgeon-made physiology has a single functional ventricle, which drives blood flow through 
the systemic circulation to the body, and no right ventricle exists to pump blood through the 
lungs. This profound alteration of blood flow or venous return contributes to early and late 
Fontan pathophysiology, including premature failure of systemic venous return, liver 
congestion and cardiac arrhythmias.  
 
1.4 WHY IS A NON-INVASIVE SOLUTION NEEDED? 
A major health challenge for this redesigned blood flow path is the lack of pressure available to 
properly and efficiently pump blood through the lungs; since only half a heart exists. Over time 
this leads to morbidity and other major complications. Today, a heart transplant is the only 
therapeutic option for these patients and medically stabilizing them in order to survive the 
organ waiting period presents a major challenge. This leads to high healthcare cost 
consumptions and a high mortality rate. The 10-year survival rate is only 60% [47]. 
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Cardiac transplantation for patients with failing Fontan physiology is a treatment option, if they 
can be medically stabilized and survive the waiting period for a donor organ. Transplantation, 
however, has an average waiting period of 6 months with a pretransplant mortality of 14% and 
an operative mortality of 27%, including a lifetime of immunosuppressive therapy and potential 
for noncompliance and graft rejection [44]. 
 
1.5 GOAL OF CLINICAL STUDY 
In order to address these major concerns we assessed the feasibility of a non-invasive, home 
therapy with the potential to reduce the complications during the heart transplant waiting 
period and ameliorate the quality of life for Fontan patients. To achieve this we tested a device 
that applies pressure to the lower extremities of the body (legs and abdomen) in a pulsating 
fashion with the goal of augmenting systemic blood flow to the pulmonary arteries. This in turn 
reduces ventricular workload, increases venous return and pulmonary perfusion, and reduces 
cardiac after load. The idea is to optimize the use of this low-cost treatment that, with the 
increase blood flow, will lead to improved health in this patient population and reduce overall 
healthcare cost over time. 
 
Specifically we attempted to reduce the chronic venous insufficiency, a hallmark of the Fontan 
physiology, by routinely administering lower body compression therapy, which we hypothesize 
will enhance flow from the great veins through the lungs. This enhancement of flow, in turn, 
should materialize into improved functional and exercise capacity. We performed a clinical pilot 
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study to evaluate this hypothesis, building on Dr. Amy Throckmortons's earlier work (n=2 
feasibility study) [48]. Our specific aims for this study included: 
1. Measure the acute physiologic benefit of external pulsation (n=2) in Fontan patients and 
assess functional improvement through exercise evaluation on a treadmill using the 
Ramp protocol. 
2. Characterize and optimize the existing pulsation technology for Fontan patients to 
readily use in the comfort of their home, rather than having to attend regular, 
outpatient appointments. 
Our hypothesis of augmenting systemic blood flow to the pulmonary arteries through the 
application of external compression originates from studying skeletal musculature during 
exercise [3 - 8]. The extension and contraction of skeletal muscle during exercise is shown to 
augment blood flow through this pumping action. This muscle pump and muscle vasodilatory 
mechanisms play important roles in increasing muscle perfusion and cardiac output during 
exercise. Jose Gonzalez-Alonso demonstrated that cardiac output can increase by 8.7 l/min 
during maximal exercise (incremental knee-extensor and cycle ergometer exercise) [3]. 
 
Compression therapy not only has similar effects on cardiovascular function during exercise [16, 
18] but similar vasodilatory effects on blood vessels [9]. Hence, we hypothesize that by applying 
external pressure to the lower extremities of the body we will not only mimic the hemodynamic 
response of the skeletal muscle pump during exercise but replicate much of the long-lasting 
benefits of exercise achieved during endurance training (e.g., increasing VO2 max, increased 
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stroke volume). Improving exercise capacity in Fontan patients, a group that suffers from 
compromised cardiovascular function, particularly during exercise [10] is expected to reduce 
the long-term mortality and morbidity rates among this patient population. 
 
The knowledge gained from this research will allow us to develop transformative technology 
which is usable for the immediate post-operative period after Fontan surgery in the home 
setting. This pneumatic device will aid patients struggling to cope with the new circulation and 
serve as a novel clinical management strategy for long-term use.  
 
1.6 PNEUMATIC COMPRESSION DEVICE/THERAPY 
The concept of applying external compression in order to elevate systemic pressures and 
manipulate blood flow has been well documented using various technologies and therapies. 
Applying external pressures to the lower body can produce similar cardiovascular results as 
performing passive leg exercises in healthy subject, increasing cardiac output, on average by 1 
ml / min [3, 16]. 
 
Applying ambulatory compression therapy that is commonly used in phlebology, J. Veraart 
(University Hospital Maastricht) conducted a study measuring the pressure augmentation in the 
deep vein (popliteal vein) when compression stockings of various pressures were worn. 
Subjects experienced an increase in venous pressure of as much as 75% when applying a 
compression stocking of 40 mmHg equivalent pressure [17]. Table 1 gives a list of some studies 
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conducted where various technologies were applied to achieve pressure augmentation and 
other hemodynamic changes after applying external compression device. 
 
 
 
 
 
 
 
 
 
 
1.6.1 Medical Anti-Shock Trouser (MAST) 
Medical anti-shock trousers were designed to stop or significantly reduce severe blood loss 
during hypovolemic or hemmorrhagic shock. This is primarily accomplished by applying a fixed 
external pressure to the lower extremities of the body. This fixed pressure maintains a systolic 
pressure of 100 mmHg by increasing impedance of blood flow to the lower half of the body. 
The result of this treatment is an increase in both interstitial and tissue pressure and decrease 
in vessel size, resulting in a reduction of transmural pressure beneath the area where pressure 
is applied. In the case of trauma circulating blood is redirected to the vital areas and allowing a 
quick stabilization of the patient [4, 16]. 
Table 1: Hemodynamic changes for Various Applied Pressures 
Results
Author
Year 
Published
Total 
Subjects Technology
Applied 
Pressure
Systolic 
Arterial 
Pressure 
(Avg.)
Diastolic 
Arterial 
Pressure 
(Avg.)
Right Atrial Pressure 
/ CVP (Avg.)
Left Atrial 
Pressure 
(Avg.)
Cardiac 
Output / 
Cardiac 
Index (Avg.) Notes
Herman A. Heck 1981 9 MAS Trousers
(Lower Boby - 
Phasic)
45-50 mmHg 69 to 89 mmHg 
(30% increase)
- RAP: 17 to 24 mmHg 
(41% increase)
9 to 16 mmHg 
(78% increase)
- Post Operative Fontan 
patients ages 7-26 years
Jeffrey C. Milliken 1986 16 MAS Trousers
(Abdominal 
Compression - 
Phasic)
30 - 45 mmHg 91 to 118.2 
mmHg (30% 
increase)
54.3 to 67.6 
mmHg (24% 
increase)
RAP: 15 to 22.9 
mmHg (53% increase)
7.4 to 14.9 
mmHg (101% 
increase)
- Post Operative Fontan 
patients; 23 months - 31 
years
Alexander V. NG 1987 12 MAS Trousers 50 mmHg 119 to 129 
mmHg (8% 
increase)
84 to 85 mmHg 
(1% increase)
- - 4,034 to 4,907 
ml/min (22% 
increase)
Healthy male sugjects 
(mean age 28). Inflated 
before and during graded 
arm cranking exercise
William Ma 2002 10 External 
Counter 
pulsation
- - - CVP: Avg. increase of 
15.3%
- CI avg. 
increase of 
7.4% from 
baseline
Pediatric Post operative 
Fontan patient (age 2 - 8)
J C J M Veraart 2003 7 Compression 
Stockings 
(Supine 
position)
18 - 40 mmHg - - Pressure increase in 
deep veins (popliteal 
vein) vs. applied: 20% 
for 18 mmHg; 31% for 
29 mmHg; 75% for 40 
mmHg
- - Adult patients with severe 
venous insufficiency
Various studies show the resulting hemodynamic changes during applied external pressures using different 
compression technologies.  
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Various studies have shown that the use of MAST while upright causes blood volume 
redistribution from the lower body to the thorax, which results in increase venous return and 
SV [19-21]. A paper by Alexander V. NG at the University of Wisconsin [16] demonstrated that 
applying this pressure to the lower extremities of the body of healthy male subjects during 
standing rest and arm exercise, MAST inflation resulted in significant increases in SV, cardiac 
output, and MABP, and a decrease in HR. The investigators inflated the MAST device to 50 
mmHG on 12 healthy male subjects and found, on average, a consistent increase in cardiac 
output of 800 ml/min and an increase in SV of ~8-13 ml, compared to MAST deflation. Mean 
arterial blood pressure was also shown to increase ~6 mmHg with MAST inflation with 
increasing work. 
 
Although to a lesser degree, Fontan patients have also show significant beneficial hemodynamic 
changes during compression therapy, on average increasing cardiac index by 7.4 % [18] and 
right atrial pressure between 40% - 50% [22, 23]. Heck et al. [22] showed that the application of 
45 – 50 mmHg of pressure through MAS trousers to post-operative Fontan patients (7-26 years) 
on average increased right atrial pressure by 44%. 
 
1.6.2 Enhanced External Counter Pulsation (EECP) 
Another compression technology utilizing this blood flow redistribution principal is the 
Enhanced external counter pulsation (EECP). This device has been FDA approved as a treatment 
modality for ischemic heart diseases. This treatment mimics the inflation and deflation of a 
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pressure-cuff, wrapped around the patient's lower extremities (from the abdomen to the 
patient's feet). The device consists of the use of a sequential inflation of 3 sets of cuffs and the 
inflation-deflation cycle is timed to the patient's electrocardiogram; the arterial pressure 
waveform is monitored noninvasively. 
 
The EECP therapy is usually carried out in an outpatient setting. Applied pressures range from 
200 mmHg to 300 mmHg.  A course of EECP treatment typically involves 35 1-hour sessions at 
the physician's office, usually 5 days a week over a 7-week period, though treatments twice per 
day have been effective as well [24]. 
 
The clinical benefits of EECP for patients with refractory angina pectoris have been well 
established [24 - 28]. The overall hemodynamic effect is to provide diastolic augmentation and 
thus increasing coronary perfusion pressure, venous return and, subsequently, cardiac output. 
In 2002, William Ma published results from a study his team conducted at the Dallas Children's 
Medical Center where they  study the effects of external counterpulsation (EC) in the pediatric 
Fontan population [18]. His safety and efficacy study attempted to show an improved cardiac 
output in the early postoperative period after the Fontan procedure. The results of this study 
showed an average increase for all enrollees in cardiac index of 7.4 L/min/m^2 and 15.3 mmHg 
for central venous pressure during EC treatment. 
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1.7 EARLY STUDY RESULTS 
While various studies have documented the 
hemodynamic effects of applying external 
compression to the lower body, very few, if any, have 
considered the modern Fontan patient population. As 
such, an early feasibility study (n=2), conducted by the 
VCU BioCirc Laboratory in early 2009, set out to 
explore this relationship among this specific study 
population [48]. The results of this study served as a starting point in setting the applied 
pressures for our current at home pilot study. 
 
This earlier study used retrofitted commercial medical antishock (MAS) trousers (David Clark 
Company, MA) to apply circumferential pressure to the lower extremities. While in the supine 
position, subjects had a catheter inserted into the femoral vein and/or artery and the 
compression treatment was carried out. The MAS-trouser pressures were set based on the 
patient's diastolic blood pressure, and with the catheter in place, the increase in venous 
pressure and cardiac output was measured. 
 
Both subjects in the study showed a significant increase in pressure levels during the 
application of the compression treatment. The data demonstrated that an almost linear 
relationship exists with the applied external pressure, satisfying the hypothesis that this 
treatment can increase venous pressure and in turn increase the blood flow to pulmonary 
Figure 2: Concept of timed compression to drive 
flow toward the heart using the retrofitted MAS 
trousers and cyclic inflation / deflation. 
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circulation. Table 2 below shows the average pressure increase for each subject compared to 
their baseline measurements. 
  
 
 
 
 
 
 
This feasibility study demonstrated the augmentation of pressure by compressing the lower 
extremities in the Fontan patients and thus served as the basis for the clinical study conducted 
in this thesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average Pressure Augmentation for Study Patients as Compared to Baseline Measurements
Cycle
Number
Applied
Pressure
(mmHg)
Systolic 
BP
(mmHg)
Systolic
Change
(mmHg)
Systolic
Change
(%)
Diastolic
BP
(mmHg)
Diastolic
Change
(mmHg)
Diastolic
Change
(%)
MAP
(mmHg)
MAP 
Change
(mmHg)
MAP
Change
(%)
Baseline 0 82 -- -- 47 -- -- 59 -- --
1 37 91.6 9.6 11.7 51.1 4.1 8.7 64.6 5.6 9.5
2 47 94.9 12.9 15.7 54.2 7.2 15.3 67.8 8.8 14.9
3 57 97.3 15.3 18.7 57.1 10.1 21.5 70.5 11.5 19.5
Baseline
1 0 117 -- -- 79 -- -- 92 -- --
2 79 130.1 13.1 11.2 86.5 7.5 9.5 101 9 9.8
3 89 127 10 8.5 85.6 6.6 8.4 98.9 6.9 7.5
P
a
ti
e
n
t 
1
P
a
ti
e
n
t 
2
Table 2: Average Pressure Augmentation for Feasibility Study Patients as compared to Baseline Measurement 
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CHAPTER 2: Methods and Materials 
 
2.1 AT HOME CLINICAL STUDY 
Given the beneficial cardiovascular response during compression therapy that has been well 
documented we developed a study protocol that specifically looks at the period following 
treatment to better assess if a lasting effect occurs. Equipped with the results from the earlier 
feasibility study (n=2), we obtained VCU IRB approval (HM #13521) in May of 2011 to test our 
hypothesis and carry out the proposed pilot study. The study was approved for five CHD 
patients with single ventricular physiology (Fontan). The results will serve as the foundation for 
evaluating this treatment in a chronic outpatient setting in adult Fontan patients where the 
treatment regimen can be optimized.  
 
Project Highlights 
 This is a novel project; the concept of using external pulsation to support pediatric and 
adult patients with this particular CHD has not been explored. A heart transplant is the 
only therapeutic option. 
 The NormaTec device used in this study is already FDA approved and commercially 
available for a related therapy. This will ensure a rapid approval for this particular 
application. 
 This device will be a low cost, non-invasive at home therapy that will drastically improve 
the health of this pediatric patient population. No home therapy exists today. 
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2.2 NORMATEC PNEUMATIC COMPRESSION DEVICE 
We used the NormaTec Pneumatic Compression Device (PCD). This is an FDA cleared external 
compression device that applies pressure to the extremities of the body, in a peristalsis process. 
The inflatable trousers are connected to a controller that is programmed to the patient's 
specifications. Various parameters are entered, such as pressure, compression time and rest 
time. 
 
 
 
 
 
 
 
 
 
Our choice to use the NormaTec technology was strongly driven by its programmable controller 
and ease of use. NormaTec's PCD stands apart from other technologies as part of a treatment 
option that is truly ambulatory with real clinical translatability. While, EECP technology has 
been studied extensively, its relatively high risk and operational complexity limit it as a viable 
option for an at home therapy. EECP treatment is administered in either an in-patient or 
medical office setting and will usually apply very high pressures in the range of 200-300 mmHg. 
With this in mind, the NormaTec device was a good choice for this study. 
Figure 3: NormaTec's Pneumatic Compression Device (PCD) 
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The pants that were provided to us by NormaTec consisted of 5 separate cells that started at 
the feet and finished at the top of the thighs. Depending on the subject's height, the pants can 
be programmed to inflate all five cells or less. For subjects with an inseam measurement less 
than 30 inches, the pants are programmed to inflate only up to the 4th cell, as was the case for 
the first patient in our group. 
 
Under typical prescription to a patient, NormaTec delivers the controller preprogrammed to 
medical mode, where the physician can choose from a number of already loaded preset 
treatments. As our protocol called for a lot tighter control of the parameters, we deviated from 
standard factory settings and programmed our controller under the classic mode. The settings 
for programing our controller under the classic mode setting included: 
 
 Total time set for the treatment session can be set in 15 minute incremental steps 
 Rest time can be set in 15 second incremental steps 
 Pressure hold time at each cell can be set in 15 second incremental steps 
 Pressure values are set in 10 mmHg incremental steps (starts at 30 mmHg and has a max 
at 100 mmHg). 
The peristaltic compression should lead to an improvement in venous return. As the trousers 
become inflated, the portion of the body under compression is pinched closed (or "occluded"), 
forcing the blood / lymphatic fluid to move further up the leg. It is expected that, after applying 
over time, this improved venous return should manifest in improved exercise capacity. 
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2.3 STUDY PROTOCOL 
The IRB approved the participation of five to ten subjects in this study. Through direct contact, 
Dr. Sam Lee, and in collaboration with Dr. William Moskowitz, recruited our subject cohort. An 
initial screening of potential study candidates was completed on the basis of age, interest, 
health status, and congenital diagnosis. Our target age for the study was between 15 – 45 years 
old. Once the subject was recruited, they were scheduled to come into Dr. Lee's office for the 
Pre-Evaluation portion of the study. This consists of: 
 Orientation on the device and how to use it. 
 Signed the consent form 
  If the subject does not meet any of the exclusion criteria, the patient will undergo a 
doppler ultrasound of the lower extremities to exclude deep vein thrombosis as a 
concern. 
 Baseline treadmill stress test, conducted on the 10th floor of the Main Hospital in the 
Pauley Heart Center. 
The subject was then discharged to their home and began the home treatment using the 
NormaTec compression device for 6 consecutive days. Daily compression treatments was 
performed for 2‐3 hours for the first four days, and for  4‐5 hours over the last two days for at 
least 2 hours per day, at the discretion of the patient. The day after the last treatment day, day 
8, exactly one week from the pre-evaluation, the study participants returned to the VCU 
Medical Center for a post‐treatment evaluation and study conclusion. The figure below 
illustrates the treatment regimen over the eight days. 
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At the end of the post-treatment medical evaluation, we conducted an exit‐interview and asked 
the study participants to fill out a Quality of Life‐based survey about their use of the pneumatic 
trousers. 
 
2.4 STUDY SUBJECT AND CLINICAL CHARACHTERISTICS 
As of November 2014, two subjects have been successfully recruited and undergone the 
pneumatic compression treatment. Dr. Sam Lee, our principal investigator, with the help of Dr. 
William Moskowitz, spent a significant amount of time attempting to recruit Fontan patients. 
Very few patients have been willing to participate primarily due to the time spent away from 
work or school required during the pre- and post-treatment exercise testing. To-date, both 
subjects have completed the treatment regimen and final evaluation. The remainder of this 
paper discusses the methods and results of these two subjects with the hope of highlighting 
initial conclusions that can be used to better analyze and assess the benefits of this treatment 
for future work, with a larger subject cohort.  
 
Pre-
Eval
2-3 hr 2-3 hr 2-3 hr 2-3 hr 4-5 hr 4-5 hr
Post-
Eval
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8
Clinical Study Protocol
Figure 4: Clinical Study Protocol. Treatment regimen from pre-stress test to post-stress test. 
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The clinical characteristics are summarized below (Table 3). Both subjects are TCPC Fontan 
patients with one having an ILT and the other an ECC connection. The mean age at the Fontan 
operation was 4 years with an interval from Fontan operation to this exercise study of 16 years. 
 
 
 
 
 
 
The only clinical condition that complicated the analysis was a heart block that was discovered 
in the second subject later in the study (Figure 12). 
2.4.1 Pre‐Treatment Evaluation 
The pre‐treatment evaluation involved a reiteration of the study objectives and a medical 
assessment of each subject to rule out any existing symptoms or conditions that meet the 
exclusion criteria. 
 
 
 
 
 
 
 
Study Subject Characteristics
Subject #1 Subject #2
Sex F M
Age (years) 17 23
Height (cm) 152 160
Weight (kg) 47 42
Cardiac Diagnosis Double Inlet Left Ventricle Double Outlet Right Ventricle
Fontan Type Lateral Tunnel (ILT) TCPC Extracardiac Conduit (ECC) TCPC
Age at Fontan Procedure (months) 46 52
Time b/w Study & Fontan Procedure (years) 14 19
Exclusion Criteria:
• uncontrolled arrhythmias
• history of pulmonary embolism and/or
deep vein thrombosis
• uncontrolled hypertension
• uncontrolled congestive heart failure
• clinically significant valvular disease
• acute myocardial infarction
• excessive tachycardia or marked
bradycardia bleeding diathesis
• a significant abdominal aortic aneurysm.
Table 3:  Study Subject Characteristics 
Table 4: Exclusion Criteria for clinical trial 
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Other Screenings Consisted of: 
 Electrocardiograms were completed to exclude patients with persistent and significant 
atrial dysrhythmias.  
 Patients were questioned about any recent episodes of chest discomfort or shortness of 
breath as well as recent prescription adjustments to medication dosages. 
  An additional screening was done to assess the patient, including blood pressure, heart 
rate, oxygen saturation, skin integrity, presence of peripheral edema, any shortness of 
breath or other discomfort, liver size, and lung auscultation. 
 As stated earlier, if the subject did not meet any of the exclusion criteria, the patient 
underwent a doppler ultrasound of the lower extremities to exclude deep vein 
thrombosis as a concern. 
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Stage Duration
(S)
Speed 
(mph)
Grade
(%)
1 30 1.0 0.0%
2 30 1.1 0.5%
3 30 1.2 1.0%
4 30 1.3 1.5%
5 30 1.4 2.0%
During Exercise Phase
2.5 TREADMILL STRESS TEST 
The primary aim of this study was to test the hypothesis 
that through this pneumatic compression therapy at 
home, the subject experiences an increase in systemic 
and pulmonary circulation. The effectiveness of this 
therapy can best be measured through a demonstrable 
improvement in exercise capacity of each subject. For 
this reason, we decided to conduct a treadmill stress 
test both before the treatment regimen, to serve as the 
baseline, and after for purposes of comparison. 
 
Treadmill stress test was executed according to a Ramp 
protocol [42]. This protocol was selected because it is routinely performed in the evaluation of 
40‐50 pediatric and adult patients per year at VCU and because it brings the subjects to their 
tolerance limit in approximately 10 minutes, thereby providing ample time for data collection 
and evaluation. Figure 5 illustrates further the details of this protocol. The workload increases 
progressively over the exercise duration. Both the speed and incline increase every 30 seconds 
until the subject reaches exhaustion and decides to stop the test. During the testing period, 
inspired and expired gases were collected with a mouthpiece the subject wore. The data was 
used to calculate the oxygen consumption and other important parameters.  
 
Figure 5: Treadmill stress test using the ramp 
protocol. 
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Primary measurements of interest during the stress test included O2 consumption (VO2), CO2 
production (VCO2), minute ventilation (VE) and heart rate (HR). Our analysis included evaluation 
of the change in peak exercise capacity by looking at parameters such as VO2max, exercise 
time, Ventilatory Equivalent Ratios (VE/VO2 & VE/VCO2), Respiratory Exchange Ratio 
(VCO2/VO2) and max heart rate.  
 
The day after concluding the treatment regimen, subjects returned to the 10th floor Main 
Hospital for a post-treatment stress test in the VCU Pauley Heart Center. Results were directly 
compared to the baseline measurements of the pretreatment evaluation. The desired outcome 
was a demonstrable improvement in functional and exercise capacity as indicated by an 
improved ability to withstand the treadmill exercise for a longer time and at a higher VO2 peak 
value.  
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2.6 NORMATEC PULSATION TREATMENT 
The treatment for the subjects occurred daily over a 2‐3 hour period and a total of 4‐5 hours 
over the last two days. I was present at the subjects house each day, with the medical 
personnel, to program the device and ensure compliance with this protocol. I also maintained 
daily communication with the subject to discuss any questions or concerns that may arise 
during the treatment. 
 
 This device is currently FDA cleared (through the 510(k) premarket notification process; 
#K013436) for use in patient with venous insufficiency; a common issue with Fontan patients.  
Nursing staff and technical personnel at NormaTec were available 24‐hours a day in the event 
assistance was needed. 
 
A blood pressure measurement was taken at the patient’s home, prior to starting treatment, 
and the pneumatic compression device was set to apply an external pressure of +15 mmHg 
above the patient’s measured diastolic pressure. The compression was automatically and 
cyclically applied for 30 minutes with a 5 minute rest period before having another 30 minute 
treatment, until completion of the treatment duration. 
 
A major difference between the technology used in this study and the first feasibility study, was 
the use of a peristaltic pulse pattern for applying the external pressure. This is more 
complicated than manually inflating and deflating the trousers, but yields better results in 
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increasing venous return. The following outlines the steps in one full inflation / deflation cycle 
of the compression device. 
1. Cell 1: rhythmic inflation/deflation up to the set pressure and pulse time for that cell 
2. Cell 1: After pulse time for Cell 1 is reached, Cell 1 holds a pressure for 10 mmHg higher 
than it pulses during the pulsing time for the next two cells (Cells 2 &3). 
3. Cell 2: rhythmic inflation/deflation up to the set pressure and pulse time for that cell 
4. Cell 2: After pulse time for Cell 2 is reached, Cell 2 holds a pressure for 10 mmHg higher 
than it pulses during the pulsing time for the next two cells. 
5. Cell 3: rhythmic inflation/deflation up to the set pressure and pulse time for that cell 
6. Cell 3: After pulse time for Cell 3 is reached, Cell 3 holds a pressure for 10 mmHg higher 
than it pulses during the pulsing time for the next two cells. 
7. 30 second pause – Cell 1 deflates 
8. Cell 4: rhythmic inflation/deflation up to the set pressure and pulse time for that cell 
9. Cell 4: After pulse time for Cell 4 is reached, Cell 4 holds a pressure for 10 mmHg higher 
than it pulses during the pulsing time for the next cells (Cell 5). 
10. 15 second pause – Cell 2 deflates 
11. Cell 5: rhythmic inflation/deflation up to the set pressure and pulse time for that cell 
12. Cell 5: After pulse time for Cell 5 is reached, Cell 5 holds a pressure for 10 mmHg higher 
than it pulsed for, until the end of the full inflation / deflation cycle. 
13. 15 second pause – Cell 3 deflates 
14. Cell 4 & 5 now both deflate 
15. Rest time begins. 
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Figure 6 below provides an illustration of a full peristaltic pulse inflation / deflation cycle for a 
given set of parameters.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Example of a full peristaltic pulse cycle using the NormaTec Pneumatic 
Compression device (PCD). Assumptions include: (1) set pulse time to 15 seconds; 
(2) set cell pressure to 30 mmHg, and (3) set rest time to 45 seconds. From start 
to finish, the total time lapse will be around 165 seconds.  
CELL 1
Pulse/Release/Hold
CELL 2
Pulse/Release/Hold
CELL 4
Pulse/Release/Hold
CELL 3
Pulse/Release/Hold
CELL 1: Deflate
CELL 2: Deflate
CELL 5
Pulse/Release/Hold
CELL 3: Deflate
CELL 4&5: 
Deflate
Rest Time Begins
Set Pulse Time: 15 sec
Cell # DurationPressure
Pulse Pressure: 30 mmHg
Hold Pressure: 40 mmHg
Pulse Pressure: 30 mmHg
Hold Pressure: 40 mmHg
Pulse Pressure: 30 mmHg
Hold Pressure: 40 mmHg
DEFLATE
Pulse Pressure: 30 mmHg
Hold Pressure: 40 mmHg
DEFLATE
Pulse Pressure: 30 mmHg
Hold Pressure: 40 mmHg
DEFLATE
DEFLATE
Baseline Pressure
Set Pulse Time: 15 sec
Set Pulse Time: 15 sec
Pause Time: 30 sec
Set Pulse Time: 15 sec
Pause Time: 15 sec
Set Pulse Time: 15 sec
Pause Time: 15 sec
Pause Time: 15 sec
Set Rest Time: 15 sec
Total Time: 165 seconds (~3 minutes)
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2.7 MILESTONES / TIMELINE 
This clinical study, titled "Pilot Study of External Pulsation Treatment for Fontan Patients" was 
approved by the IRB on September 6, 2013 with the current team in place (VCU IRB Protocol 
Number: HM13521). The team consists of: 
 Sam Lee, M.D.; Assistant Professor of Pediatric Cardiology (Principal Investigator) 
 William B. Moskowitz, M.D.; Chairman, Pediatric Cardiology (Sub/Co-Investigator) 
 Joseph Hernandez; Biomedical Engineering Graduate Student (Graduate Student). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 7: Project milestone timeline. Starting from the original IRB approval through the 
second subject. 
• In May of 2011, The original IRB submission,
under Dr. Amy Throckmorton, was approved.
Change of  PI
IRB Approval 
Under New 
Team
Subject #1
IRB Renewal
Subject #2
Original IRB 
Approval
• In August of 2013, Dr. Amy Throckmorton moves
to a new institution and Dr. Sam Lee replaces her as
Principal Investigator.
• In September of 2013, approved our proposed
roster changed, with the PI change.
• On Monday, March 4, 2014, the first subject began
treatment and finished on March 10, 2014.
• In March 2014, the IRB approved our renewal for
another year.
• On Wednesday, May 7, 2014, the second subject
began treatment and finished on May 16, 2014.
Project Milestone Timeline
A Preliminary Study On External Counterpulsation System: 
An Alternative Therapeutic Option for Fontan Patients 
Joseph Hernandez 
Virginia Commonwealth University 
 
26 
 
The results of this study will allow development of technology that is usable for the immediate 
post-operative period after Fontan surgery. Following this pilot study, extramural funding could 
be sought in order to conduct larger multi-center trials.  
 
2.8 CALCULATIONS AND ANALYSIS 
In order to validate the success of the treatment on the Fontan physiology, we assessed 
improvements in a number of parameters related to improved exercise capacity. Below are the 
primary endpoints that were compared among the pre- and post- treatment stress test results. 
1. Increase in exercise duration. 
2. Increase in maximal/peak oxygen uptake (VO2 peak). 
3. A decrease in the slope of minute ventilation versus total CO2 production (VE/VCO2 
slope). As measured at the point before anaerobic threshold is reached. 
4. An increase in the Oxygen Uptake Efficiency Slope (OUES). A steeper slope represents a 
more efficient VO2, showing that a smaller ventilation quantity is required for a given 
VO2 value. 
5. Improved anaerobic threshold (AT) capacity: 
a. Increase in the VO2 at which AT occurs 
b. A decrease in AT as a % of VO2 Max 
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Because we sought to improve exercise capacity, our primary end points included VO2 max as a 
proxy for energy expenditure and an increase in exercise time to show an increase in work load. 
Because it is commonly difficult among CHD patients to reach a true VO2max, VO2 peak was 
used instead. This can be seen in Figures 9 and 11, where no plateaus in VO2 were ever 
reached. 
 
Exercise tests that reached a peak respiratory exchange ratio (VCO2 / VO2) of ≥ 1.0 during the 
exercise phase were considered maximally performed [10]. The peak oxygen uptake (VO2 peak) 
and peak minute ventilation was used (instead of maximal values) and calculated by averaging 
the final 30 seconds of the test. The slope of ventilation versus carbon dioxide elimination 
(VE/VCO2 slope) was determined using measurements from minute 6 and 1.5, for subjects 1 
and 2 respectively, of the exercise phase until the ventilatory threshold point had been 
reached. 
 
The oxygen uptake efficiency slope (OUES) was calculated from the linear relationship of VO2 
versus the logarithm of minute ventilation using the equation VO2=aLog(VE) + b. The data was 
used starting at the second minute of the exercise phase until the end [29 - 30]. A steeper 
slope, reflects a more efficient oxygen consumption, where a smaller ventilation quantity is 
required for a certain VO2 value. 
 
The ventilatory threshold (VT), the moment that the VCO2 increased out of proportion 
compared with VO2, was determined using the ventilatory equivalent method VT(VE) [31]. VT is 
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an important index of cardiorespiratory function during exercise in patients with CHD [32 - 33]. 
Ventilatory threshold has been widely applied clinically as an index of the functional state of 
patients with various cardiorespiratory diseases, used to predict the ability of a subject to 
sustain a given work rate for a prolonged period without metabolic (lactic) acidosis.  
 
Since both VO2 and VCO2 fluctuate breath to breath, due to irregularities in ventilation, this 
data has been processed by a 9-s moving average filter in order to visually identify the VT [34]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A Preliminary Study On External Counterpulsation System: 
An Alternative Therapeutic Option for Fontan Patients 
Joseph Hernandez 
Virginia Commonwealth University 
 
29 
 
 
 
CHAPTER 3: Results 
The VCU IRB approved a total of 5 – 10 subjects for this study. Due to difficulty in recruiting, we 
have only successfully recruited two subjects so far. Although a small sample size, we 
attempted to fully analyze the results from this group with the hopes of establishing a frame of 
reference for future work. We anticipate that results will vary with additional subjects, but will 
provide us with additional data sets for drawing more exact conclusions from data generated so 
far. Treadmill stress-test Results for both subjects are listed in Table 5. 
 
 
 
 
 
 
 
 
 
3.1 COMPRESSION THERAPY 
The first subject showed the most compelling results from the therapy. This subject was able to 
reach the desired applied external pressures, in line with the study protocol. Follow up 
evaluation was conducted immediately following the last day of treatment.  The treatment was 
not tolerated well by either patient initially. Similar complaints of discomfort of the lower 
Table 5:  Cardiopulmonary exercise test results for both subjects 
 
Subject #1 Subject #2
Pre- Post- % Change Pre- Post- % Change
Exercise Duration (Sec) 690 760 10.1% 670 730 9.0%
Heart Rate (bpm) at Rest 70 71 1.4% 60 67 11.7%
Heart Rate (bpm) at Max 147 153 4.1% 67 108 61.2%
MAP (mmHg) at Rest 112.0 96.0 (14.3%) 90.3 94.7 4.8%
MAP (mmHg) at Max 120.3 103.3 (14.1%) 107.7 105.7 (1.9%)
VO2 Peak (ml/Kg/min) 24.93 36.75 47.4% 27.35 31.15 13.9%
VE Peak (L/min) 35.43 53.75 51.7% 46.15 59.88 29.7%
RER Peak 0.99 1.01 2.6% 1.20 1.29 7.4%
VO2 at VT (ml/Kg/min) 17.87 30.5 - 22.6 26.38 -
% VT/ VO2 Peak 71.7% 83.0% - 82.6% 84.7% -
VE/VCO2 Slope 27.838 25.099 (9.8%) 27.36 31.763 16.1%
OUES 1,850.1 2,442.9 32.0% 1,903.4 2,039.8 7.2%
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extremities were made by the subjects. The applied external pressure had to be initially 
adjusted and ramped up to the desired level that the protocol called for. 
 
 
 
 
 
 
 
 
For the second subject, the target applied external pressures (+15 mmHg above diastolic) was 
only achieved for three of the six treatment days. Because of scheduling related issues, we 
were not able to get the subject into the Pauley Heart Center for the stress test and post-
treatment evaluation until three days after the last day of treatment; a factor that could have 
potentially contributed to the more subtle improvements in exercise capacity.  
 
 
 
 
 
 
 
Treatment Regimen - Subject #1
Applied Pressure (mmHg)
Day # Day
Time of 
Day
Blood 
Pressure 
(mmHg)
# of Cells 
Activated Initial Final
Treatment 
Duration 
(minutes) Notes
1 Tuesday Night 125 / 73 4 90 60 120
Applied pressure < diastolic 
after 30 minutes
2 Wednesday Night 108 / 70 4 60 80 120
Applied pressure > diastolic 
after 60 minutes
3 Thursday Night 118 / 68 4 70 80 120
Applied pressure > diastolic 
for the entire treatment
4 Friday Night 118 / 72 4 70 80 150
Applied pressure > diastolic 
after 30 minutes
5 Saturday Morning 115 / 73 4 70 80 150
Applied pressure > diastolic 
after 30 minutes
6 Sunday Morning 110 / 65 4 70 80 240
Applied pressure > diastolic 
for the entire treatment
Treatment Regimen - Subject #2
Applied Pressure (mmHg)
Day # Day
Time of 
Day
Blood 
Pressure 
(mmHg)
# of Cells 
Activated Initial Final
Treatment 
Duration 
(minutes) Notes
1 Thursday Night 110 / 65 5 70 40 120 Started at 70 mmHg, dropped to 60 mmHg after 10 
min, after 30 min reduced to 40 mmHg
2 Friday Night 128 / 75 5 50 70 120 Started at 50 mmHg, raised to 70 mmHg after 30 min, 
raised again to 80 mmHg after 60 min, but had to 
immediatley drop back to 70 mmHg
3 Saturday Morning 122 / 70 5 60 80 120 Applied pressure > diastolic after 30 minutes
4 Sunday Morning 118 / 70 5 70 70 120 Applied pressure < diastolic for the entire treatment
5 Monday Night 125 / 67 5 70 80 120 Applied pressure > diastolic for the entire treatment
6 Tuesday Night 127 / 65 5 70 70 210 Applied pressure > diastolic for the entire treatment
* Subject's applied pressure was above diastolic pressure for only 3 out of the 6 treatment days.
Table 6:  PCD treatment Regimen for subject 1 
Table 7: PCD treatment Regimen for subject 2 
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3.2 EXERCISE DURATION AND OXYGEN UPTAKE 
Both subjects exercised to exhaustion without any adverse events during the exercise testing. 
Total exercise duration time during the exercise phase improved by approximately 10% for each 
subject (Table 5). 
 
We considered exercise tests with a peak respiratory exchange rate (RER peak) ≥ 1.0 during the 
exercise phase as maximally performed. As can be seen in Figure 8, this occurred at or slightly 
after the exercise phase for the first subject. It was therefore difficult to use maximal exercise 
parameters like VO2 peak and Max heart rate to demonstrate the improvements on exercise 
capacity for the first subject. However, we did include this analysis to show a complete and 
thorough analysis. 
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Figure X: RER (VCO2 / VO2) vs. Time (mm:ss) Subject #1 (Pre- and Post- Treatment Stress Test)
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Figure 8: RER (VCO2/VO2) vs. Time (HH:MM:SS) for subject 1. Showing both pre- and post- stress test results. 
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As can be seen in Table 5, because of this single ventricular physiology, blood perfusion is 
compromised and a lower VO2 peak is reached compared to a healthy subject. Typical VO2 max 
seen in Fontan patients are around 30 ml/kg/min; half of a healthy subject [1]. The primary 
means of improving this in our study is by increasing venous return and therefore cardiac 
output.  
 
As expected, during the graded exercise test, oxygen consumption increases linearly with 
increases in exercise intensity. Total aerobic capacity (VO2 peak) is reached at a lower level than 
a healthy subject, primarily because of blood flow deficiency. We can see the effects of the 
compression treatment, improving aerobic capacity by 47% (Figure 9). Since RER ≥ 1.00 was not 
reached until the end (or after) of the exercise phase, we do not know if this improvement is 
due primarily to increased exercise duration and not the treatment itself.  
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Figure 9: VO2 (ml/kg/min) vs. Time (HH:MM:SS) for subject 1. Showing pre- and post- stress test results. 
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As can be seen in Figure 10 there was a modest improvement in the max heart rate achieved 
for the first subject. The time it took to reach max HR increased by 7%. These values are in line 
with published results. Fontan patients maximal heart rate during exercise tends to be reduced 
by approximately 80% of what is expected in a health subject [1].  
 
 
 
 
 
 
 
 
 
The second subject was able to achieve maximal exercise levels during the treadmill test. RER 
crossed 1.0 at 8 minutes and 20 seconds during the pre-treatment test (170 seconds before the 
end of the exercise phase) and at 9 minutes during the post-treatment test (190 seconds before 
the end of the exercise) (Figure 15). A modest improvement in VO2 peak occurred for the 
second subject, increasing capacity by 13.9% after the treatment regimen (Figure 11). 
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Figure 10: Heart Rate (bpm) vs. Time (HH:MM:SS) for subject 1. Showing pre- and post- stress est results. 
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The second subject showed no real heart rate response to the exercise stress test (Figure 12). It 
was not until after the study started that the medical team identified a heart block (AV Nodal 
block) that caused these skewed results. Because of this almost constant heart rate, cardiac 
output must have augmented primarily on the back of a marked increase in blood pressure 
(given a constant resistance). Systolic blood pressure increased by 40% during the pre-
treatment stress test and by as much at 64% during last test. 
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3.3 VENTILATORY THRESHOLD AND OXYGEN UPTAKE EFFICIENCY SLOPE 
Ventilatory threshold is an important parameter to measure as it can be used to predict the 
ability of a subject to sustain a given work rate for a prolonged period without metabolic (lactic) 
acidosis. In our study we measure VT noninvasively by analyzing the continuous measurements 
of ventilaotry and gas exchange variables during the stress test. 
 
VT for CHD patients seem to occur closer to VO2 max / peak than does for healthy subjects; the 
VT/Peak VO2 ratios for CHD subjects are higher than healthy subjects (67.6 % vs. 44.6%) [35]. 
Although the first subject was not able to reach a maximal exercise lever during stress testing, 
we include analysis on ventilatory threshold to show a complete data set for our group. As 
discussed earlier, peak respiratory exchange rate (RERpeak) of ≥ 1.00 was only reached after 
the exercise test for the first subject. Therefore, this is not a reliable indication of improved 
exercise capacity for this subject. 
 
 
 
 
 
 
 
 
 
Figure 13: Determination of Ventilatory Threshold for subject 1. Showing pre- and post- stress test results. 
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Among Fontan patients, minute ventilation is 
notably altered during an exercise bout. At rest, 
these patients seem to have near normal 
ventilation (9 – 10 L/min), however during peak 
exercise; the minute ventilation is significantly 
less than that of normal subjects [1]. This 
altered cardiorespiratory response to exercise, 
in many cases, makes it difficult to utilize VT as a 
parameter for exercise testing. We therefore 
include other submaximal exercise parameters 
in this analysis. 
 
The second subject was in fact able to achieve maximal exercise levels during testing (Figure 15) 
and we found it appropriate to include maximal exercise parameters in our analysis of the 
second subject. Although the heart rate response was blunted, we observed positive trends in 
the ventilatory threshold data. 
 
To obtain a better sense of overall improvement in exercise capacity for the second subject, we 
looked at the ventilatory equivalent ratios to understand if the subject reached their anaerobic 
threshold later after going through the treatment regimen (Figure 14). Here we are looking for 
the point where a marked change in slope occurred between VE/VO2 and VE/VCO2. Before 
treatment this threshold was reached around 8 minutes and 10 seconds into the stress test. 
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This VO2 of 22.6 ml/kg/min represents 82.6% of the VO2 peak, pre-treatment. By the end of the 
week, the subject was able to reach their aerobic capacity later, around 8 minutes and 50 
seconds, improving their time by 8%. 
 
As confirmed by both sets of graphs (Figure 14), the subject increased the VO2 at which VT 
occurred by 3.7 ml/kg/min.  
 
We were able to visually identify the points where the VE/VO2 curve, which has been flat or 
decreasing from the beginning until after 8 minutes into the exercise phase, and now, begins to 
rise as the VE/VCO2 curve remains constant or decreasing. 
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The primary clinical assessment of interest is the evaluation of aerobic capacity as a response to 
compression therapy. While VO2 peak provides an accurate and objective indication of maximal 
aerobic capacity, it is only useful if the patient is able to perform at maximal effort. This level is 
rarely reached by Fontan patients. As an alternative, we have included analysis on the Oxygen 
Efficiency Slope (OUES) as a proxy for aerobic capacity. Figure 16 provides visual details on the 
resulting OUES changes after the treatment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Oxygen efficiency slope (OUES). (a) pre-treatment subject 1, (b) post-treatment subject 1, (c) pre-
treatment subject 2, (d) post-treatment subject 2. 
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Both subjects were able to achieve more efficient oxygen consumption post-treatment as 
indicated by a steeper slope in OUES. The first subject experience an increase in OUES of 
approximately 32% (2,443 vs. 1,850) and the second subject showed an increase as well, 
although to a lesser degree (7.2%).  
 
OUES measurements were started at 90 seconds (because of 9-s moving average) until 90% of 
the test phase had been reached [10]. These values show that both subjects are relatively 
healthy as compared to other Fontan subjects. Healthy subjects tend to have OUES values in 
the range of 1,500 to 2,000 with CHD patients experiencing 75% - 80% of those values [10, 29]. 
 
3.4 VE/VCO2 SLOPE 
The first subjects demonstrated a modest improvement in VE/VCO2 slope. The slope of 
ventilation versus carbon dioxide elimination was determined using measurements beginning 
from minute 6 of the test phase (due to a large amount of noise in the beginning), up to the VT 
determined from the graphs. The true stopping point is the respiratory compensation point, but 
due to difficulty in accurately identify this point visually, we utilized VT instead. The second 
subject had an increase of VE/VCO2 slope after the compression therapy of 16%. For this 
subject measurements began at 1 minute and 30 seconds (as as result of using a 9-s moving 
average). 
 
As far as this parameter is concerned, these two subjects seem to be relatively healthy Fontan 
subjects. Larger studies have shown and average slope for Fontan patients to be around 34.5 
A Preliminary Study On External Counterpulsation System: 
An Alternative Therapeutic Option for Fontan Patients 
Joseph Hernandez 
Virginia Commonwealth University 
 
40 
 
and approximately 127% greater than their healthy counterparts [10]. This observation is in 
agreement with the results seen in the OUES analysis above. 
 
An elevated slope is expected from CHD patients since an elevated VE/VCO2 slope is inversely 
related to cardiac output. In our patient population, a diminished pulmonary perfusion leads to 
this elevated slope state. Ideally, as cardiorespiratory measurements improve with long-term 
pneumatic compression therapy, a reduction in VE / VCO2 slope should be experienced. 
 
3.5 CHAPTER SUMMARY 
The pressure applied during the treatment regimen was not well supported by the tests 
subjects. The recommended external pressure of 15 mmHg above the diastolic was not 
achieved and adjusted down for the comfort to the subject. On average, 70 mmHg was the 
highest pressure applied that was tolerated by either participant. 
 
Only one of the two subjects performed maximally during the exercise stress test. As such, it is 
appropriate to assess the viability of this treatment using submaximal exercise parameters 
across both study subjects. These parameters do show, particularly OUES, an improvement in 
exercise capacity after compression treatment. OUES improved by 32% and 7.2% for the first 
and second subject, respectively. 
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The second subject was able to perform maximally during the stress test. Considering both 
maximal and submaximal parameters we did observe an improvement in all parameters, with 
the exception of VE / VCO2 slope. 
 
Regardless of the point at which true VO2 max occurs, we can confidently see an improvement 
in ventilatory threshold as a result of the compression treatment. Both subjects increased their 
aerobic capacity, demonstrating greater oxygen consumption at the time of anaerobic 
metabolism transition than during pre-treatment stress test. VO2 at the point of VT increased 
by 70% and 17% for the first and second subject, respectively.  
 
These preliminary results are encouraging and suggest that this therapy could be very beneficial 
to Fontan patients. Overall, there was an improvement in exercise duration time, VO2peak, 
ventilatory threshold, and OUES with only VE / VCO2 slope having mixed results for our patient 
cohort. 
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CHAPTER 4: Discussion 
 
The aim of this study was to show improvements in cardiorespiratory measurements among 
Fontan patients after applying external pressure to the lower extremities of the body. Our 
results among the two subjects so far have shown a moderately beneficial improvement in 
exercise capacity after the compression therapy.  
 
The objective is to mitigate complications that result from long-term single-ventricle 
physiology. The primary strategy is to increase venous return and thus stroke volume. Improved 
exercise capacity, and hence cardiorespiratory measures, can be observed as a proxy for 
improved health among this patient population. The result of the Fontan surgery tends to be a 
diminished exercise tolerance and ventricular dysfunction [12-15]. At rest, (cardiac index, 
stroke index and systolic blood pressure) these subjects will have normal or slightly subnormal 
parameters as compared to healthy subjects. However, during dynamic exercise, notable 
differences are observed, showing that these patients are unable to adequately respond to 
exercise. This is why, when compared to healthy subjects, single ventricular patients tend to 
have an abnormal cardiorespiratory response to exercise. This can include:  
 A blunted heart rate response. 
 Limited ability to increase stroke volume with exercise, due to impaired ventricular 
function and difficulty in increasing ventricular preload. Cardiac Index has been found to 
be as much as 22% greater during exercise for healthy, age-matched subjects as 
compared to Fontan patients [36]. 
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 Most 10 year follow-up studies document myocardial dysfunction and grade II failure in 
about 70% of patients [37]. 
 The ventricle becomes dilated, hypertrophic, and hypocontractile, with deterioration in 
both systolic and diastolic function. 
The absence of the pulmonary ventricular pump results in a low pulmonary blood flow, 
considering that at this point blood flow is primarily driven by venous pressure. Because of the 
redirection of the vena cava to the pulmonary arteries, there is very little pressure gradient to 
push along blood flow to the lungs. Studies have shown very little, if any, pressure gradients 
exists across the surgical connections (e.g., RA-PA) for Fontan patients [36]. With so little 
hydrostatic pressure contributing to venous return, blood flow is mainly being driven passively 
(osmotic pressure) into the lungs. This pressure increase upstream leads to chronically elevated 
central venous pressure, a hallmark of the Fontan physiology. Common CVP at rest among this 
patient population can be 3 times that of their healthy counterparts (14 mmHg vs. 4 mmHg) 
[38]. This is why the dominant limiting determinant of ventricular function is preload in these 
patients. 
 
During an intense exercise bout, Fontan patients reach exhaustion much quicker than their 
healthy counterparts. They will produce lactic acid much quicker and lactic acidosis may occur. 
Respiratory rates and ventilation are expected to spike as they expire off more CO2 and reach 
anaerobic metabolism much quicker. This effect is primarily driven by a low cardiac output 
response during intense exercise resulting in a lower VO2 max among Fontan patients. Stroke 
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volume, not heart rate has been found to be responsible for this depressed cardiac output 
during exercise [38]. 
 
Maximal Vs. Sub-Maximal Exercise Parameters 
There is an inherent bias in the exercise protocol that seems to favor experience with the 
equipment. The majority of test subjects perform better, as it relates to exercise time, the 
second time on the treadmill equipment. In a scenario where maximal exercise was not 
reached (RER peak ≥ 1.0), then it is unreliable to look at the change in VO2 peak as an indication 
of increased exercise capacity since all that is being captured is improved duration on the 
treadmill where a higher VO2 peak should be expected. This was the case with the first subject 
(Figure 8 and 15).  
 
Both Bossers [10] and Akkerman [30] argue that finding true VO2 Max is mainly limited to 
healthy adult subjects who can actually perform maximally during a graded exercise testing. 
These subjects have to keep pushing themselves long enough for VO2 to reach the plateau in 
the face of continuing exercise and increasing workload. Both argue that in the pediatric 
population and Fontan patients, a true plateau in oxygen uptake is seldom attained. Bossers 
conducted a large multi-center study with 110 Fontan patients less than 18 years old and 
showed that as much as 20% of the subjects were not able to reach a maximal exercise state 
(RER ≥ 1.00) and "Submaximal" exercise parameters were used (e.g., VE/VCO2 slope and 
Oxygen Uptake Efficiency slope). 
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Akkerman goes as far as stating that for these patients, using VO2 peak during exercise is not 
appropriate as a proxy for improved cardiovascular health since this measurement can in fact 
be strongly influenced by the patient's motivation, the selected exercise protocol, and the 
experience of the tester. 
 
Although the second subject was able to perform at a sufficient level of effort, as indicated by 
RERpeak ≥ 1.0, there was still no clear plateau of VO2. Thus, it is not certain that a true VO2 max 
level was ever reached (Figure 11). Therefore, if both subjects did not achieve a true VO2 max, 
we then were really measuring VO2 peak. If the subjects improved their exercise duration 
primarily because of their experience with the equipment, an improvement in VO2peak should 
then be expected but reveals very little about whether or not the pneumatic compression 
treatment was in fact effective at improving the patients exercise capacity. For this reason, it is 
important to additionally analyze submaximal exercise parameters, which includes VE/VCO2 
slope, Ventilatory Threshold, and Oxygen Uptake Efficiency Slope (OUES). 
 
Other Considerations 
The second subject was not able to perform the post-treatment stress test immediately 
following the last day of treatment, due to scheduling conflicts at the lab. The post-treatment 
stress test was performed three days after the last day of treatment. Although not the primary 
reason, this could have caused some major variation between the two subjects results post 
treatment. However, both of the subjects seem to be relatively healthy Fontan patients, as 
indicated by their VO2 peak, VE/VCO2 slope and OUES. This may also lead us to believe that our 
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current cohort of patients may not experience as much of an improvement as one might see in 
Fontan patient with poor health, a failing Fontan physiology for instance. Until a greater sample 
size is studied we cannot be sure that this data represents the extent of the clinical benefit of 
this compression treatment. 
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CHAPTER 5: Future work and Conclusion 
 
Various studies exploring the effects of applying external pressure mainly focus on the post-
operative period of the Fontan procedure. Very little data exists on a much later period after 
the surgery. This study presents results on exercise capacity after applying a compression 
therapy regimen on a modern Fontan population. Most studies focus on the result of 
compression during the therapy. 
 
With only two subjects, there is not enough data to draw a statistically significant conclusion. 
Although we have been able to thoroughly analyze the results so far with the hopes to gain 
additional clarity once other subjects are recruited and further studied. With a larger cohort of 
subjects we aim to lay the ground work for future chronic outpatient studies. If successful this 
technology could serve as a preventive measure and long-term clinical treatment alternative for 
Fontan patients. 
 
Recruiting Efforts 
Our team had difficulties successfully recruiting subjects to this study. There are a number of 
reasons that could have contributed to the poor participation. Principal among this is the time 
commitment required. Not only did the patient have to block off two full weekdays for the pre- 
and post-treatment stress test, but also a portion of every evening and weekend. A study 
stipend could help address this issue by partly off-setting the subjects' expense for the time 
spent participating in the study. This is particularly important when time off work or missed 
school is required. 
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Target Applied Pressure 
The applied external pressures used during the treatment were based on the clinical results of 
the first feasibility study. The protocol called for an applied external pressure set to 15 mmHg 
greater than their diastolic pressure. In many instances this meant applying pressures greater 
than 85 mmHg. This was not well tolerated and patients complained of discomfort, having to 
stop treatment and adjust the applied pressure. We attempted to reach pressures as close to 
the protocol as was tolerated by the subject. For future studies, an appropriate applied 
pressure should be explored. It is conceivable to think that one would only have to apply 
enough pressure to distribute blood flow from the lower extremities of the body to the central 
venous system and large enough to provide a gradient across the surgical connection and 
increase blood flow. This could be between 30 – 40 mmHg, but more work needs to be done. 
 
Testing Bias 
Most subjects perform better on the treadmill stress test after the initial test since they are 
better acquainted with the equipment. This was not a factor that was anticipated during the 
study protocol designed. As a way to reduce this bias, before the initial baseline stress test is 
conducted, each subject could first perform the treadmill exercise test at least once. We can 
then establish a true base-line once the study begins.  
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Starting Early 
The impact the therapy has related to the age of the Fontan patients is worth considering for 
future work. Studies have shown that VO2 peak decreases over time with an annual decline 
between 1.25% [11] and 2.6% [14]. In order to see the maximal benefit from this kind of 
therapy, an early start might be important to consider. The time between this study and the 
Fontan procedure among our subjects was 14 and 19 years. With our limited sample size, we do 
not have the benefit of observing results across various age groups and results might be poorer 
than the mean observed results for other published data. Average time since the Fontan 
procedures ranged anywhere from 4 months post operation to 14 years [1, 10, 36, 38]. 
 
In order for the proposed treatment to have true clinical application it will need to have lasting 
benefits that are materialized in improved exercise capacity in the long-run. A consistent 
attenuation of the chronic venous insufficiency found in the Fontan patients will need to be 
achieved in order to avoid long term complications such as liver congestion, cardiac 
arrhythmias and other morbidity.  
 
Long-term Treatment Benefits (Exercise Training Like Results) 
The benefits of exercise training on various exercise parameters have been well documented 
including improving VO2 max by 16% - 46% in a cohort of healthy subjects performing a 2-3 
times per week for 8-16 week exercise regimen [39]. Exercise training has shown improved 
cardiorespiratory responses to exercise over time by increasing blood volume and thus a 
greater venous return. Increased maximal cardiac output in endurance trained athletes has 
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been shown to be primarily a result of greater stroke volume, rather than an increase in 
maximal heart rate, which in fact tends to be lower in these athletes. Training can lead to an 
increase in efficacy of systolic contraction and essentially a more complete emptying of the 
heart by a forcible systolic contraction. It is not unreasonable for us the think that with the 
proper treatment regimen for our pneumatic compression device, a Fontan patient can 
experience a similar, albiet to a lesser degree, improvement in long-term exercise capacity and 
reduction of venous insufficiency.  
 
There will need to be some discussion on a proposed long-term treatment regimen for future 
studies using this pneumatic compression therapy. Arthur M. Feldman [40] showed in a 6 
month follow up that subjects who received a treatment regimen of 35 1-hour sessions over a 
period of 7 to 8 weeks using the EECP technology were able to improve their exercise time, 
although peak VO2 did not improve with therapy.   
 
There is also a genetic component that has been identified which can dictates how effective 
exercise training can be on improving exercise capacity and cardiovascular adaptability [41]. It 
has been suggested that as much as 25% - 50% of the general population's variability in VO2 
Max is due to genetic differences. Subjects who are predisposed to responding to exercise 
training have increased VO2 max by as much as 50% and those that are not predisposed have 
show no improvements. While the Fontan patient will benefit from an improved venous return 
during treatment, there might be a similar genetic factor that might limit the long-term 
conditioning effect seen in exercise training among endurance athletes.  
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Possible reason for subject to subject variability: 
The total capopulmonary connection (TCPC), a modified version of the original Fontan 
operation, is most often performed using either an intra-artrial lateral tunnel (ILT) or an 
extracardiac conduit (ECC). It has been demonstrated that ILT patient group tends to have 
diminished cardiovascular function as compared to their ECC counterpart. VO2 peak has been 
found to be significantly lower in this group as well as a steeper VE/VCOs slope [10]. This may 
describe some of the differences in results among our group. The first subject, an ILT Fontan 
patient, was not able to perform maximally in either pre- or post-treatment exercise test. More 
data needs to be collected before definitive conclusions can be made. 
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